Company intelligence / Profile preview

Purimed

unknown, unknown, South Koreapubchem.ncbi.nlm.nih.gov ↗

Ownership: Private
Development stage: Commercial

Overview

Purimed Co., Ltd. has disclosed a pharmaceutical composition comprising an extract from Citrus aurantium with anti-diabetic properties. There is no public data indicating clinical trial results or commercialized products as of now. PURIMED LTD (UK) is active but no specific drug development summary is available.

Therapeutic areas: Metabolic Disorders
Modalities: Plant extract-based therapySmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Purimed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Purimed.

Explore the full profile